Postoperative Outcomes in Patients Undergoing Orthopaedic Surgery Within 90 Days of Coronavirus Disease 2019

Introduction: Coronavirus disease 2019 (COVID-19) has resulted in a global pandemic with several hundred million infections worldwide. COVID-19 causes systemic complications that last beyond the initial infection. It is not known whether patients who undergo elective orthopaedic surgeries after COVID-19 are at increased risk of complications. The purpose of this study was to evaluate whether patients who undergo orthopaedic procedures after recent COVID-19 diagnosis are at increased risk of complications compared with those who have not had a recent COVID-19 diagnosis. Methods: The TriNetX Research Network database was queried for patients undergoing elective orthopaedic surgeries from April 2020 to January 2022 in the following subspecialties: arthroscopic surgery, total joint arthroplasty, lumbar fusion, upper extremity surgery, foot and ankle (FA) surgery. Cohorts were defined by patients undergoing surgery with a diagnosis of COVID-19 from 7 to 90 days before surgery and those with no COVID-19 diagnosis 0 to 90 days before surgery. These cohorts were propensity-score matched based on differences in demographics and comorbidities. The matched cohorts were evaluated using measures of association analysis for complications, emergency department (ER) visits, and readmissions occurring 90 days postoperatively. Results: Patients undergoing arthroscopic surgery were more likely to experience venous thromboembolism (VTE) (P = 0.006), myocardial infarction (P = 0.001), and ER visits (P = 0.001). Patients undergoing total joint arthroplasty were more likely to experience VTE (P < 0.001), myocardial infarction (P < 0.001), pneumonia (P< 0.001), and ER visits (P = 0.037). Patients undergoing lumbar fusion were more likely to experience VTE (P = 0.016), infection (P < 0.001), pneumonia (P < 0.001), and readmission (P = 0.006). Patients undergoing upper extremity surgery were more likely to experience VTE (P = 0.001) and pneumonia (P = 0.015). Patients undergoing foot and ankle surgery were more likely to experience VTE (P < 0.001) and pneumonia (P < 0.001). Conclusion: There is an increased risk of complications in patients undergoing orthopaedic surgery after COVID-19 infection; all cohorts were at increased risk of VTE and most at increased risk of pneumonia. Additional investigation is needed to stratify the risk for individual patients.

[1]  E. Akl,et al.  American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients , 2022, Blood Advances.

[2]  A. Trimaille,et al.  Cardiovascular manifestations secondary to COVID-19: A narrative review , 2022, Respiratory Medicine and Research.

[3]  D. Jevsevar,et al.  Making a Joint Decision Regarding the Timing of Surgery for Elective Arthroplasty Surgery After Being Infected With COVID-19: A Systematic Review , 2022, The Journal of Arthroplasty.

[4]  C. Russ,et al.  Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study , 2022, Journal of Thrombosis and Thrombolysis.

[5]  D. Parums.  Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19 , 2022, Medical Science Monitor.

[6]  R. Guzman,et al.  Perioperative Complications of Patients with SARS-CoV-2 Infection in Neurosurgery , 2022, Journal of clinical medicine.

[7]  A. Torkaman,et al.  Evaluation of early complications, outcome, and mortality in Coronavirus Disease 2019 (COVID-19) infection in patients who underwent orthopedic surgery , 2022, BMC Musculoskeletal Disorders.

[8]  J. Grauer,et al.  COVID-positive ankle fracture patients are at increased odds of perioperative surgical complications following open reduction internal fixation surgery , 2021, PloS one.

[9]  A. Fraga,et al.  How the COVID-19 pandemic changed postoperative infections in urology wards: A retrospective cohort study from two urology departments. , 2021, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[10]  Max A. Schumm,et al.  Short-term perioperative outcomes among patients with concurrent asymptomatic and mild SARS-CoV-2 infection: A retrospective, multicenter study , 2021, Surgery.

[11]  H. Sandhu,et al.  The Risk of Postoperative Complications After Major Elective Surgery in Active or Resolved COVID-19 in the United States , 2021, Annals of surgery.

[12]  H. Ueno,et al.  How has the COVID-19 pandemic affected gastrointestinal surgery for malignancies and surgical infections? , 2021, Nagoya journal of medical science.

[13]  N. Harlaar,et al.  Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: A Dutch, multicenter, matched-cohort clinical study , 2020, Surgery.

[14]  S. Abate,et al.  Postoperative mortality among surgical patients with COVID-19: a systematic review and meta-analysis , 2020, Patient Safety in Surgery.

[15]  S. Calza,et al.  Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy. , 2020, JAMA surgery.

[16]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[17]  R. Agha,et al.  World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) , 2020, International Journal of Surgery.

[18]  C. Siu,et al.  Short- and potential long-term adverse health outcomes of COVID-19: a rapid review , 2020, Emerging microbes & infections.

[19]  Y. Ikari,et al.  Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases , 2019, Cardiovascular Diabetology.